John Thomas - 01 Jun 2026 Form 4 Insider Report for GENELUX Corp (GNLX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Jun 2026, 20:35:01 UTC
Prior SEC filing
03 Mar 2026
Next SEC filing
18 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Zindrick, J.D., Attorney-in-Fact

Key filing fact

John Thomas filed Form 4 for GENELUX Corp (GNLX) on 02 Jun 2026.

Key facts

  • This page summarizes John Thomas's Form 4 filing for GENELUX Corp (GNLX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 02 Jun 2026, 20:35.

Change

  • Previous filing in this sequence was filed on 03 Mar 2026.
  • Current net transaction value: -$29,801.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001939103 Primary reporting owner

Thomas John

Relationship
Director
Address
C/O GENELUX CORPORATION, 2625 TOWNSGATE ROAD, SUITE 230, WESTLAKE VILLAGE
Signature
/s/ Thomas Zindrick, J.D., Attorney-in-Fact
Signature date
02 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GNLX transaction

Common Stock

Sale

Transaction value
$29,801
Shares
-10,000
Change %
-2.1%
Price
$2.98
Shares after
472,784
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2025.

Footnote F2

The weighted average sale price for the transaction reported was $2.9801, and the range of prices were between $2.94 and $3.05. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .